Product Program year 2023 Source: CMS Open Payments

X-Tack Endoscopic HeliX Tacking System

Device Endoscopic Tissue Approximation Device

PDI 10811955020770

Open in the dashboard

General payments

$399,563

1,339 payments

Research payments

$0

0 payments

Through program year 2023, $399,563 in general payments and $0 in research payments were reported against X-Tack Endoscopic HeliX Tacking System (Endoscopic Tissue Approximation Device).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

3 rows
Year Kind Amount Payments
2023 General $12,319 12
2022 General $323,369 911
2021 General $63,875 416

Breakdown

Who paid General payments · program years 2021–2023
  1. Apollo Endosurgery US Inc $399,563 1,339 payments
Top recipients General payments · program year 2023
  1. Christopher Chapman Gastroenterology · Chicago, IL $11,875 96% · 2 payments
  2. Nikalesh Reddy Surgery · Punta Gorda, FL $140 1% · 1 payment
  3. Boris Borges Ondarse Surgery · Port Charlotte, FL $140 1% · 1 payment
  4. Prasun Jalal Transplant Hepatology · Houston, TX $30 <1% · 1 payment
  5. Kathryne Blair Surgery · London, KY $28 <1% · 1 payment

The top 5 of 11 recipients; each share is of general payments naming this product in 2023.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2023
  1. Gastroenterology Internal Medicine $11,943 97% · 5 practitioners
  2. Surgery $309 3% · 3 practitioners
  3. Transplant Hepatology Internal Medicine $30 <1% · 1 practitioner
  4. Internal Medicine $22 <1% · 1 practitioner
  5. Anesthesiology $16 <1% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2023. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2023
  1. Illinois $11,875 96% · 1 recipient
  2. Florida $280 2% · 2 recipients
  3. Kentucky $56 <1% · 2 recipients
  4. Utah $31 <1% · 2 recipients
  5. Texas $30 <1% · 1 recipient

The top 5 of 7 states; each share is of general payments naming this product in 2023 where a state was reported.

The top 25 states, free in the app

1,339 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2023

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record